Cipla
Search results
Jun 25, 2024 · Sun Pharma. News. All News Announcement Recos. India to make drugs for diabetes, obesity under PLI by 2026, says report. | News. 28 Jun 2024, 01:17PM IST. India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a government official speaking to Reuters.
1 day ago · Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharmaceutical Industries, including: Last traded price 1529.0, Market capitalization: 366738.35, Volume: 840140, Price-to-earnings ratio 38.32, Earnings per share 39.91. Get a complete picture of Sun Pharmaceutical Industries's performance through our comprehensive blend of fundamental and ...
1 day ago · The US drug regulator had inspected Sun Pharma's Dadra unit back in December 4-15 last year, following which, it classified the facility as 'Official Action Indicated.'
Sun Pharmaceuticals Industries Limited, commonly known as Sun Pharma, on Monday, June 24, 2024, through a BSE exchange filing announced that the company had successfully completed the merger of ...
6 days ago · Reported Consolidated quarterly numbers for Sun Pharmaceutical Industries are: Net Sales at Rs 11,982.90 crore in March 2024 up 9.63% from Rs. 10,930.67 crore in March 2023. Quarterly Net Profit ...
May 22, 2024 · Indian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on Wednesday, helped by strong performance in its key U.S. and domestic markets.
May 22, 2024 · Pharma major Sun Pharmaceutical Industries Ltd. on May 22 reported a better-than-expected consolidated net profit of Rs 2,654.5 crore for the March quarter, up 34 percent from the year-ago...
Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by strong sales in its domestic and U.S....
Jan 31, 2024 · India's largest drugmaker Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in the key domestic and U.S. markets.
Jan 31, 2023 · Drug major Sun Pharmaceutical Industries on Tuesday said its consolidated net profit for Q3 FY23 rose 5% to ₹ 2,166 crore as compared to ₹ 2,058.8 crore year-on-year (YoY). Analysts expected...
